James C Furnivall - Net Worth and Insider Trading

James C Furnivall Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James C Furnivall owns 3 companies in total, including Birchtech Corp (BCHT) , EPIRUS Biopharmaceuticals Inc (EPRSQ) , and DexCom Inc (DXCM) .

Click here to see the complete history of James C Furnivall’s form 4 insider trades.

Insider Ownership Summary of James C Furnivall

Ticker	Comapny	Transaction Date	Type of Owner
BCHT	Birchtech Corp	2014-08-14	10 percent owner
EPRSQ	EPIRUS Biopharmaceuticals Inc	2005-11-15	10 percent owner
DXCM	DexCom Inc	2005-04-13	10 percent owner

James C Furnivall Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

James C Furnivall Ownership Network

Ownership Network List of James C Furnivall

No Data

Ownership Network Relation of James C Furnivall

James C Furnivall Owned Company Details

What does Birchtech Corp do?

Who are the key executives at Birchtech Corp?

James C Furnivall is the 10 percent owner of Birchtech Corp. Other key executives at Birchtech Corp include Chief Financial Officer Fiona Fitzmaurice , Chief Financial Officer Gregory R Powell , and director & 10 percent owner & Pres. & Sec. & Treas. Richard Macpherson .

Birchtech Corp (BCHT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Birchtech Corp (BCHT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Birchtech Corp (BCHT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Birchtech Corp (BCHT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Birchtech Corp Insider Transactions

No Available Data

What does EPIRUS Biopharmaceuticals Inc do?

Who are the key executives at EPIRUS Biopharmaceuticals Inc?

James C Furnivall is the 10 percent owner of EPIRUS Biopharmaceuticals Inc. Other key executives at EPIRUS Biopharmaceuticals Inc include Chief Financial Officer Thomas A. Shea , Chief Business Officer Vincent Aurentz , and director & Chief Executive Officer Amit Munshi .

EPIRUS Biopharmaceuticals Inc (EPRSQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of EPIRUS Biopharmaceuticals Inc (EPRSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of EPIRUS Biopharmaceuticals Inc (EPRSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

EPIRUS Biopharmaceuticals Inc (EPRSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

EPIRUS Biopharmaceuticals Inc Insider Transactions

No Available Data

What does DexCom Inc do?

Who are the key executives at DexCom Inc?

James C Furnivall is the 10 percent owner of DexCom Inc. Other key executives at DexCom Inc include Chief Human Resources Officer Sadie Stern , SVP & Research & Development Jacob Steven Leach , and SVP & Finance & CAO Jereme M Sylvain .

DexCom Inc (DXCM) Insider Trades Summary

Over the past 18 months, James C Furnivall made no insider transaction in DexCom Inc (DXCM). Other recent insider transactions involving DexCom Inc (DXCM) include a net sale of 30,958 shares made by Sadie Stern , a net sale of 18,313 shares made by Micheal Jon Brown , and a net sale of 7,911 shares made by Steven Robert Pacelli .

In summary, during the past 3 months, insiders sold 3,604 shares of DexCom Inc (DXCM) in total and bought 0 shares, with a net sale of 3,604 shares. During the past 18 months, 316,886 shares of DexCom Inc (DXCM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 316,886 shares.

DexCom Inc (DXCM)'s detailed insider trading history can be found in Insider Trading Tracker table.

DexCom Inc Insider Transactions

No Available Data

James C Furnivall Mailing Address

Above is the net worth, insider trading, and ownership report for James C Furnivall. You might contact James C Furnivall via mailing address: C/o Alterna Capital Partners Llc, 15 River Road, Suite 230, Wilton Ct 06897.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.